Preventive Care
Feature
New heart failure guidelines prioritize prevention
The latest update to U.S. guidelines for heart failure management, released at the end of April , puts unprecedented emphasis on heart failure...
News from the FDA/CDC
FDA: Fluoroquinolone use not linked to retina detachment, aortic problems
The FDA has found no evidence of a link between fluoroquinolone usage and retinal detachment or aortic aneurysm and dissection.
Conference Coverage
Roux-en-Y bests sleeve gastrectomy for weight loss
ORLANDO – Sleeve gastrectomy is gaining in popularity, but Roux-en-Y beats it for long-term weight loss.
Conference Coverage
VIDEO: Stroke risk in women deserves greater attention
BOSTON – Texas neurologist Louise McCullough, MD, PhD, is determined to help women live longer by urging neurologists to focus on the unique risks...
Commentary
DTC genetic health risk tests: Beware
The Food and Drug Administration recently authorized 23andMe to provide consumers with results of germline DNA sequence variants associated with...
Conference Coverage
ACC/AHA vs. USPSTF statin guidelines
The ACC/AHA guidelines for preventive statin therapy would cover an estimated 9 million more U.S. adults than the USPSTF guidelines.
News
FDA approves first home genetic health risk test
Consumers do seem to want to know.
Conference Coverage
Is there clinical benefit to activity trackers?
SAN DIEGO – Wearable activity trackers may help improve patients’ physical fitness, but alone they do not promote physical activity or improve...
From the Journals
Weight fluctuations linked to higher mortality, CV events
Weight fluctuations – like the typical pattern of weight loss followed by partial or total regain that affects most people attempting to lose...
Conference Coverage
Preoperative VTEs occurred in 10% of cancer patients
SEATTLE – Those with preoperative VTEs were significantly more likely to experience postoperative complications.
Conference Coverage
VIDEO: FOURIER and SPIRE show lower LDL is better for longer
Two blockbuster trials, FOURIER and SPIRE, showed that lowering LDL to extremely low levels reduced cardiovascular events.